The pharmacokinetics, pharmacodynamics, safety and tolerability of NN2211, a new long-acting GLP-1 derivative, in healthy men
Henrik Agersø(Novo Nordisk (Denmark)), Milan Zdravković(Novo Nordisk (Denmark))
Cited by 505
Related Papers
No related papers found
Powered by citation graph analysis